Prescription tracking program amendments.

Plain English Breakdown

The bill summary text is not provided officially, so some parts of the explanation are based on interpretation of the bill's content.

Changes to Prescription Tracking Program

The bill allows the board of pharmacy to share certain information from a prescription tracking program with other states and for research purposes, while keeping patient details private.

What This Bill Does

• Allows the board of pharmacy to release non-personal information from the prescription tracking program for educational, research or public information purposes.
• Permits the board of pharmacy to create agreements with other states to share relevant data about controlled substance prescriptions when it may assist in preventing inappropriate use.

Who It Names or Affects

• The Wyoming Board of Pharmacy
• Other state boards that might enter into data sharing agreements

Terms To Know

Controlled substances

Drugs regulated by the government because they can be addictive or dangerous.

Prescription tracking program

A system that monitors and records prescription drug information to prevent misuse.

Limits and Unknowns

• The bill does not specify which other states might enter into data sharing agreements.
• It is unclear how the board of pharmacy will decide what non-personal information can be shared for research or public education purposes.

Current Bill Text

20LSO-0209
2020
STATE OF WYOMING
20LSO-0209
Numbered
2.0

SENATE FILE NO. SF0073

Prescription tracking program amendments.

Sponsored by: Senate Labor, Health and Social Services Committee

A BILL

for

AN ACT relating to controlled substances; authorizing the board of pharmacy to release information from the prescription tracking program as specified; and providing for an effective date.

Be It Enacted by the Legislature of the State of Wyoming:

Section 1.

W.S. 35
‑
7
‑
1060(c)(v) and by creating a new paragraph (vii) is amended to read:

35
‑
7
‑
1060.

Controlled substance prescription tracking program.

(c)

The tracking program shall not be used to infringe on the legal use of a controlled substance. Information obtained through the controlled substance prescription tracking program is confidential and may not be released and is not admissible in any judicial or administrative proceeding, except as follows:

(v)

The board may release information that does not identify individual patients, practitioners, pharmacists or pharmacies, for educational, research or public information purposes;
and

(vii)

The board may establish a data sharing agreement with other states for purposes of this section and may release information to those states when the release of the information may be of assistance in preventing or avoiding inappropriate use of controlled substances.

Section 2
.

This act is effective July 1, 2020
.

(END)

1
SF0073